vs
FrontView REIT, Inc.（FVR）与Spero Therapeutics, Inc.（SPRO）财务数据对比。点击上方公司名可切换其他公司
FrontView REIT, Inc.的季度营收约是Spero Therapeutics, Inc.的1.3倍（$16.5M vs $12.6M），Spero Therapeutics, Inc.净利率更高（250.7% vs -24.9%，领先275.6%）
FVR vs SPRO — 直观对比
营收规模更大
FVR
是对方的1.3倍
$12.6M
净利率更高
SPRO
高出275.6%
-24.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.5M | $12.6M |
| 净利润 | $-4.1M | $31.5M |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | -24.9% | 250.7% |
| 营收同比 | — | 24080.8% |
| 净利润同比 | — | 250.9% |
| 每股收益（稀释后） | $-0.19 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRSPRO
| Q4 25 | $16.5M | $12.6M | ||
| Q3 25 | $16.8M | $0 | ||
| Q2 25 | $17.6M | $0 | ||
| Q1 25 | $16.2M | $12.0K | ||
| Q4 24 | — | $52.0K | ||
| Q3 24 | $14.5M | $65.0K | ||
| Q2 24 | — | $114.0K | ||
| Q1 24 | — | $140.0K |
净利润FVRSPRO
| Q4 25 | $-4.1M | $31.5M | ||
| Q3 25 | $4.0M | $-7.4M | ||
| Q2 25 | $-2.9M | $-1.7M | ||
| Q1 25 | $-833.0K | $-13.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.4M | $-17.1M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-12.7M |
营业利润率FVRSPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -122758.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -28604.6% | ||
| Q2 24 | — | -16720.2% | ||
| Q1 24 | — | -9987.1% |
净利率FVRSPRO
| Q4 25 | -24.9% | 250.7% | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | -16.5% | — | ||
| Q1 25 | -5.1% | -115550.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -16.7% | -26380.0% | ||
| Q2 24 | — | -15668.4% | ||
| Q1 24 | — | -9049.3% |
每股收益（稀释后）FVRSPRO
| Q4 25 | $-0.19 | $0.56 | ||
| Q3 25 | $0.19 | $-0.13 | ||
| Q2 25 | $-0.16 | $-0.03 | ||
| Q1 25 | $-0.06 | $-0.25 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.5M | $40.3M |
| 总债务越低越好 | $314.3M | — |
| 股东权益账面价值 | $391.2M | $59.0M |
| 总资产 | $854.4M | $68.9M |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
现金及短期投资FVRSPRO
| Q4 25 | $13.5M | $40.3M | ||
| Q3 25 | $19.6M | $48.6M | ||
| Q2 25 | $8.4M | $31.2M | ||
| Q1 25 | $3.3M | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
总债务FVRSPRO
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FVRSPRO
| Q4 25 | $391.2M | $59.0M | ||
| Q3 25 | $385.2M | $26.5M | ||
| Q2 25 | $369.9M | $32.8M | ||
| Q1 25 | $324.7M | $33.8M | ||
| Q4 24 | — | $46.1M | ||
| Q3 24 | $1.0K | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
总资产FVRSPRO
| Q4 25 | $854.4M | $68.9M | ||
| Q3 25 | $846.8M | $54.2M | ||
| Q2 25 | $856.5M | $62.1M | ||
| Q1 25 | $860.8M | $77.7M | ||
| Q4 24 | — | $110.5M | ||
| Q3 24 | $1.0K | $135.2M | ||
| Q2 24 | — | $149.9M | ||
| Q1 24 | — | $167.7M |
负债/权益比FVRSPRO
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.1M | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FVRSPRO
| Q4 25 | $42.1M | $-8.4M | ||
| Q3 25 | $8.3M | $17.4M | ||
| Q2 25 | $9.3M | $-17.7M | ||
| Q1 25 | $8.1M | $-4.0M | ||
| Q4 24 | — | $-23.4M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $-18.7M | ||
| Q1 24 | — | $5.9M |
现金转化率FVRSPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
